Literature DB >> 21131912

Alzheimer disease: MRI and CSF biomarkers in AD--accuracy and temporal change.

Niels D Prins1, John C van Swieten.   

Abstract

Alzheimer disease (AD) biomarkers reflect specific features of AD pathology. These biomarkers may be used in the diagnosis and staging of AD, or may act as surrogate end points in clinical trials. Thus, a thorough understanding of the diagnostic accuracy of and longitudinal change in cerebrospinal fluid and MrI AD biomarkers is important.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21131912     DOI： 10.1038/nrneurol.2010.173

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


  5 in total

1.  Diagnostic impact of CSF biomarkers in a local hospital memory clinic.

Authors:  Maartje I Kester; Leo Boelaarts; Femke H Bouwman; Raymond L Vogels; Erwin R Groot; Evert J van Elk; Marinus A Blankenstein; Wiesje M van der Flier; Philip Scheltens
Journal:  Dement Geriatr Cogn Disord       Date:  2010-06-03       Impact factor: 2.959

2.  Serial MRI and CSF biomarkers in normal aging, MCI, and AD.

Authors:  P Vemuri; H J Wiste; S D Weigand; D S Knopman; J Q Trojanowski; L M Shaw; M A Bernstein; P S Aisen; M Weiner; R C Petersen; C R Jack
Journal:  Neurology       Date:  2010-07-13       Impact factor: 9.910

3.  Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people.

Authors:  Geert De Meyer; Fred Shapiro; Hugo Vanderstichele; Eugeen Vanmechelen; Sebastiaan Engelborghs; Peter Paul De Deyn; Els Coart; Oskar Hansson; Lennart Minthon; Henrik Zetterberg; Kaj Blennow; Leslie Shaw; John Q Trojanowski
Journal:  Arch Neurol       Date:  2010-08

4.  Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade.

Authors:  Clifford R Jack; David S Knopman; William J Jagust; Leslie M Shaw; Paul S Aisen; Michael W Weiner; Ronald C Petersen; John Q Trojanowski
Journal:  Lancet Neurol       Date:  2010-01       Impact factor: 44.182

Review 5.  Multimodal techniques for diagnosis and prognosis of Alzheimer's disease.

Authors:  Richard J Perrin; Anne M Fagan; David M Holtzman
Journal:  Nature       Date:  2009-10-15       Impact factor: 49.962
  5 in total
  2 in total

1.  Exercise-induced cognitive plasticity, implications for mild cognitive impairment and Alzheimer's disease.

Authors:  Philip P Foster; Kevin P Rosenblatt; Rodrigo O Kuljiš
Journal:  Front Neurol       Date:  2011-05-06       Impact factor: 4.003

2.  Associations of the cerebrospinal fluid hepatocyte growth factor with Alzheimer's disease pathology and cognitive function.

Authors:  Li-Jing Zhao; Zuo-Teng Wang; Ya-Hui Ma; Wei Zhang; Qiang Dong; Jin-Tai Yu; Lan Tan
Journal:  BMC Neurol       Date:  2021-10-06       Impact factor: 2.474
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.